Skip to content

Nasdaq · CIK 0001723128

AMRX Amneal Pharmaceuticals, Inc.

Insider trading from SEC Form 4. Last filing 20 d ago. Close $19.91 on Oct 9, 2026, +105% from the 52-week low and -3% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company

Price and insider trades, last year

AMRXOct 9, 2026 · close 19.91

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Amneal Pharmaceuticals, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
17WeakGautam Patel
director
sell
$761k
94,906 shares
-6%+16% from low-12% from high
32WeakGautam Patel
director
sell
$453k
56,426 shares
-3%+12% from low-16% from high
50ModerateNikita Shah
Executive Vice President
sell
$372k
49,140 shares
-11%+9% from low-18% from high
51ModerateJohn Kiely
director
sell
$380k
50,000 shares
-16%+9% from low-18% from high
18WeakGautam Patel
director
sell
$69k
8,668 shares
-1%+14% from low-14% from high
15WeakGautam Patel
director
sell
$664k
80,000 shares
-4%+7% from low-11% from high
52ModerateTushar Bhikhubhai Patel
owner
sell
$42M
5,000,000 shares
-9%+14% from low-5% from high
61NotableEmily Peterson Alva
director
sell
$712k
80,000 shares
-32%+17% from low-3% from high
65NotableTasos Konidaris
Executive Vice President & CFO
sell
$891k
100,000 shares
-14%+17% from low-3% from high
72NotableJason B. Daly
EVP, Chief Legal Officer
sell
$792k
90,000 shares
-73%+17% from low-3% from high
65NotableAndrew S Boyer
Executive Vice President
sell
$1.1M
125,000 shares
-30%+17% from low-3% from high
31WeakGautam Patel
director
sell
$712k
80,000 shares
-4%+14% from low-5% from high
15WeakGautam Patel
director
sell
$651k
80,000 shares
-4%+6% from low-12% from high
13WeakGautam Patel
director
sell
$501k
62,590 shares
-3%+5% from low-13% from high
6WeakGautam Patel
director
sell
$139k
17,410 shares
-1%+1% from low-16% from high
26WeakJohn Kiely
director
sell
$143k
17,058 shares
-6%-
55ModerateDeborah M. Autor
director
sell
$334k
40,000 shares
-43%-
60NotableJason B. Daly
SVP, Chief Legal Officer
sell
$115k
13,665 shares
-100%-
66NotableJason B. Daly
SVP, Chief Legal Officer
sell
$376k
43,657 shares
-76%-

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 17, 2026J Kevin Buchi
director
GGift
Class A Common Stock
-20,445$0.00$075,07720 d ago
Sep 11, 2026J Kevin Buchi
director
MOption exercise
Class A Common Stock
+20,445$14.45$295k95,52227 d ago
Sep 11, 2026J Kevin Buchi
director
MOption exercise
Stock Optionderivative
-20,445$0.00$0027 d ago
Sep 1, 2026Andrew S Boyer
Executive Vice President
GGift
Class A Common Stock
-80,000$0.00$0193,64639 d ago
Jun 16, 2025Gautam Patel
director
SOpen-market sale
Class A Common Stock10b5-1
-94,906$8.02$761k1,609,144Jun 18, 2025
Jun 10, 2025Gautam Patel
director
SOpen-market sale
Class A Common Stock
-56,426$8.02$453k1,704,050Jun 12, 2025
May 16, 2025Nikita Shah
Executive Vice President
SOpen-market sale
Class A Common Stock
-49,140$7.58$372k388,929May 19, 2025
May 12, 2025John Kiely
director
SOpen-market sale
Class A Common Stock
-50,000$7.59$380k257,433May 13, 2025
May 5, 2025Deborah M. Autor
director
MOption exercise
Class A Common Stock
+40,258--93,660May 8, 2025
May 5, 2025Paul M Meister
director
MOption exercise
Class A Common Stock
+56,361--784,053May 8, 2025
May 5, 2025Emily Peterson Alva
director
MOption exercise
Class A Common Stock
+40,258--211,029May 8, 2025
May 5, 2025J Kevin Buchi
director
MOption exercise
Class A Common Stock
+40,258--40,258May 8, 2025
May 5, 2025Gautam Patel
director
MOption exercise
Class A Common Stock
+40,258--1,760,476May 8, 2025
May 5, 2025John Kiely
director
MOption exercise
Class A Common Stock
+40,258--307,433May 8, 2025
May 5, 2025Shlomo Yanai
director
MOption exercise
Class A Common Stock
+40,258--285,985May 8, 2025
May 5, 2025Jeffrey P. George
director
MOption exercise
Class A Common Stock
+40,258--309,795May 8, 2025
May 5, 2025Ted C Nark
director
MOption exercise
Class A Common Stock
+40,258--341,029May 8, 2025
May 5, 2025Paul M Meister
director
MOption exercise
Restricted Stock Unitsderivative
-56,361$0.00$00May 8, 2025
May 5, 2025Deborah M. Autor
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 5, 2025John Kiely
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 5, 2025Gautam Patel
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 5, 2025Emily Peterson Alva
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 5, 2025Jeffrey P. George
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 5, 2025Ted C Nark
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 5, 2025Shlomo Yanai
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 6, 2025Shlomo Yanai
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 5, 2025J Kevin Buchi
director
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 6, 2025Emily Peterson Alva
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 6, 2025Paul M Meister
director
AGrant or award
Restricted Stock Unitsderivative
+48,747$0.00$048,747May 8, 2025
May 6, 2025Gautam Patel
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 6, 2025Jeffrey P. George
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 6, 2025John Kiely
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 6, 2025Ted C Nark
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 6, 2025Deborah M. Autor
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 6, 2025J Kevin Buchi
director
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
May 2, 2025Gautam Patel
director
SOpen-market sale
Class A Common Stock10b5-1
-3,768$8.00$30k1,725,118May 6, 2025
May 5, 2025Gautam Patel
director
SOpen-market sale
Class A Common Stock10b5-1
-4,900$8.00$39k1,720,218May 6, 2025
Apr 1, 2025Gautam Patel
director
SOpen-market sale
Class A Common Stock10b5-1
-80,000$8.30$664k1,728,886Apr 2, 2025
Mar 14, 2025Tushar Bhikhubhai Patel
owner
SOpen-market sale
Class A Common Stockindirect: By a Limited Liability Company Controlled by a Family Trust
-5,000,000$8.35$42M48,578,209Mar 17, 2025
Mar 10, 2025J Kevin Buchi
director
GGift
Class A Common Stock
-262,072$0.00$00Mar 12, 2025
Mar 5, 2025Emily Peterson Alva
director
SOpen-market sale
Class A Common Stock
-80,000$8.90$712k170,771Mar 7, 2025
Mar 5, 2025Jason B. Daly
EVP, Chief Legal Officer
SOpen-market sale
Class A Common Stock
-43,064$8.88$382k79,542Mar 7, 2025
Mar 5, 2025Andrew S Boyer
Executive Vice President
SOpen-market sale
Class A Common Stock
-125,000$8.89$1.1M290,106Mar 7, 2025
Mar 5, 2025Tasos Konidaris
Executive Vice President & CFO
SOpen-market sale
Class A Common Stock
-100,000$8.91$891k621,882Mar 7, 2025
Mar 6, 2025Jason B. Daly
EVP, Chief Legal Officer
SOpen-market sale
Class A Common Stock
-46,936$8.73$410k32,606Mar 7, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
MOption exercise
Class A Common Stock
+36,232--345,871Mar 5, 2025
Mar 3, 2025Gautam Patel
director
SOpen-market sale
Class A Common Stock10b5-1
-80,000$8.90$712k1,808,886Mar 5, 2025
Mar 3, 2025Chintu Patel
Co-CEO
MOption exercise
Class A Common Stock
+579,710--1,092,276Mar 5, 2025
Mar 3, 2025Chirag K. Patel
President & Co-CEO
MOption exercise
Class A Common Stock
+579,710--1,092,276Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
MOption exercise
Class A Common Stock
+45,290--595,309Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
MOption exercise
Class A Common Stock
+22,645--22,645Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
MOption exercise
Class A Common Stock
+39,251--315,555Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
FTax withholding
Class A Common Stock
-18,533$8.76$162k327,338Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
FTax withholding
Class A Common Stock
-6,943$8.76$61k15,702Mar 5, 2025
Mar 3, 2025Chintu Patel
Co-CEO
FTax withholding
Class A Common Stock
-274,307$8.76$2.4M817,969Mar 5, 2025
Mar 3, 2025Chirag K. Patel
President & Co-CEO
FTax withholding
Class A Common Stock
-279,527$8.76$2.4M812,749Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
FTax withholding
Class A Common Stock
-16,373$8.76$143k578,936Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
FTax withholding
Class A Common Stock
-20,077$8.76$176k295,478Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
MOption exercise
Class A Common Stock
+45,872--373,210Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
MOption exercise
Class A Common Stock
+57,340--636,276Mar 5, 2025
Mar 4, 2025Chintu Patel
Co-CEO
MOption exercise
Class A Common Stock
+92,592--910,561Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
MOption exercise
Class A Common Stock
+49,694--345,172Mar 5, 2025
Mar 4, 2025Chirag K. Patel
President & Co-CEO
MOption exercise
Class A Common Stock
+92,592--905,341Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
MOption exercise
Class A Common Stock
+38,226--53,928Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
FTax withholding
Class A Common Stock
-23,464$8.76$206k349,746Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
FTax withholding
Class A Common Stock
-10,864$8.76$95k43,064Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
FTax withholding
Class A Common Stock
-24,374$8.76$214k611,902Mar 5, 2025
Mar 4, 2025Chirag K. Patel
President & Co-CEO
FTax withholding
Class A Common Stock
-47,361$8.84$419k857,980Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
FTax withholding
Class A Common Stock
-25,419$8.76$223k319,753Mar 5, 2025
Mar 4, 2025Chintu Patel
Co-CEO
FTax withholding
Class A Common Stock
-46,528$8.84$411k864,033Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
MOption exercise
Class A Common Stock
+144,928--494,674Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
MOption exercise
Class A Common Stock
+181,159--793,061Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
MOption exercise
Class A Common Stock
+90,580--133,644Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
MOption exercise
Class A Common Stock
+157,005--476,758Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
FTax withholding
Class A Common Stock
-74,131$8.76$649k420,543Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
FTax withholding
Class A Common Stock
-80,309$8.76$704k396,449Mar 5, 2025
Mar 3, 2025Chintu Patel
Co-CEO
MOption exercise
Performance-Based Restricted Stock Unitsderivative
-579,710$0.00$00Mar 5, 2025
Mar 3, 2025Chirag K. Patel
President & Co-CEO
MOption exercise
Performance-Based Restricted Stock Unitsderivative
-579,710$0.00$00Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
FTax withholding
Class A Common Stock
-92,663$8.76$812k700,398Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
FTax withholding
Class A Common Stock
-31,338$8.76$275k102,306Mar 5, 2025
Mar 3, 2025Chintu Patel
Co-CEO
AGrant or award
Performance-Based Restricted Stock Unitsderivative
+890,410$0.00$0890,410Mar 5, 2025
Mar 3, 2025Chirag K. Patel
President & Co-CEO
AGrant or award
Performance-Based Restricted Stock Unitsderivative
+890,410$0.00$0890,410Mar 5, 2025
Mar 4, 2025Nikita Shah
Executive Vice President
MOption exercise
Class A Common Stock
+35,879--456,422Mar 5, 2025
Mar 4, 2025Tasos Konidaris
Executive Vice President & CFO
MOption exercise
Class A Common Stock
+43,981--744,379Mar 5, 2025
Mar 4, 2025Andrew S Boyer
Executive Vice President
MOption exercise
Class A Common Stock
+38,194--434,643Mar 5, 2025
Mar 4, 2025Jason B. Daly
EVP, Chief Legal Officer
MOption exercise
Class A Common Stock
+35,879--138,185Mar 5, 2025
Mar 3, 2025Chintu Patel
Co-CEO
AGrant or award
Restricted Stock Unitsderivative
+239,726$0.00$0239,726Mar 5, 2025
Mar 3, 2025Chirag K. Patel
President & Co-CEO
AGrant or award
Restricted Stock Unitsderivative
+239,726$0.00$0239,726Mar 5, 2025
Mar 4, 2025Nikita Shah
Executive Vice President
FTax withholding
Class A Common Stock
-18,353$8.84$162k438,069Mar 5, 2025
Mar 4, 2025Tasos Konidaris
Executive Vice President & CFO
FTax withholding
Class A Common Stock
-22,497$8.84$199k721,882Mar 5, 2025
Mar 4, 2025Andrew S Boyer
Executive Vice President
FTax withholding
Class A Common Stock
-19,537$8.84$173k415,106Mar 5, 2025
Mar 4, 2025Jason B. Daly
EVP, Chief Legal Officer
FTax withholding
Class A Common Stock
-15,579$8.84$138k122,606Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
MOption exercise
Restricted Stock Unitsderivative
-36,232$0.00$036,232Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
MOption exercise
Restricted Stock Unitsderivative
-45,290$0.00$045,290Mar 5, 2025
Mar 3, 2025Jason B. Daly
EVP, Chief Legal Officer
MOption exercise
Restricted Stock Unitsderivative
-22,645$0.00$022,645Mar 5, 2025
Mar 3, 2025Andrew S Boyer
Executive Vice President
MOption exercise
Restricted Stock Unitsderivative
-39,251$0.00$039,252Mar 5, 2025
Mar 4, 2025Chintu Patel
Co-CEO
MOption exercise
Restricted Stock Unitsderivative
-92,592$0.00$0277,778Mar 5, 2025
Mar 4, 2025Chirag K. Patel
President & Co-CEO
MOption exercise
Restricted Stock Unitsderivative
-92,592$0.00$0277,778Mar 5, 2025
Mar 3, 2025Nikita Shah
Executive Vice President
MOption exercise
Restricted Stock Unitsderivative
-45,872$0.00$091,743Mar 5, 2025
Mar 3, 2025Tasos Konidaris
Executive Vice President & CFO
MOption exercise
Restricted Stock Unitsderivative
-57,340$0.00$0114,679Mar 5, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

AMRX insider trading: Amneal Pharmaceuticals, Inc. | InsiderTell